logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

NSCLC: first real-world data on pemetrexed maintenance therapy

Results corroborate clinical trials, with pemetrexed-bevacizumab offering best results.